Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.

• McComb M Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA.
• Krikheli M Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA.
• Uher T Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
• Browne RW Department of Biotechnical and Clinical Laboratory Sciences, State University of New York, Buffalo, NY, USA.
• Srpova B Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
• Oechtering J Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
• Maceski AM Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
• Tyblova M Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
• Jakimovski D Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA.
• Ramasamy DP Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA.
• Bergsland N Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA; IRCCS, Fondazione Don Carlo Gnocchi, Milan, Italy.
• Krasensky J Department of Radiology, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Czech Republic.
• Noskova L Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
• Fialova L Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
• Weinstock-Guttman B Department of Neurology, State University of New York, Buffalo, NY, USA.
• Havrdova EK Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
• Vaneckova M Department of Radiology, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Czech Republic.
• Zivadinov R Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA; Center for Biomedical Imaging at Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA.
• Horakova D Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
• Kuhle J Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
• Ramanathan M Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA; Department of Neurology, State University of New York, Buffalo, NY, USA. Electronic address: Murali@Buffalo.Edu.

Show more…

Apolipoproteins

Blood-brain barrier

Brain lesions

Cerebrospinal fluid

Cholesterol

Disease onset

Lipid

MRI

Multiple sclerosis

Neurofilament light chain